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Abstract
Background: Dual energy x-ray absorptiometry (DXA) is widely used for body composition
measurements in normal-weight and overweight/obese individuals. The limitations of bone
densitometers have been frequently addressed. However, the possible errors in assessing body
composition in overweight individuals due to incorrect positioning or limitations of DXA to
accurately assess both bone mineral density and body composition in obese individuals have not
received much attention and are the focus of this report.
Discussion: We discuss proper ways of measuring overweight individuals and point to some
studies where that might not have been the case. It appears that currently, the most prudent
approach to assess body composition of large individuals who cannot fit under the scanning area
would be to estimate regional fat, namely the regions of thigh and/or abdomen. Additionally, using
two-half body scans, although time consuming, may provide a relatively accurate measurement of
total body fat, however, more studies using this technique are needed to validate it.
Summary: Researchers using bone densitometers for body composition measurements need to
have an understanding of its limitations in overweight individuals and address them appropriately
when interpreting their results. Studies on accuracy and precision in measurements of both bone
and soft tissue composition in overweight individuals using available densitometers are needed.
Background
Dual energy x-ray absorptiometry (DXA) is widely used by
clinicians and researchers for evaluation of bone status
and soft tissue composition. While the principles of DXA
technology could be found elsewhere [1-3] and are not
the focus of this report, we address them briefly for better
understanding of the discussion to follow. The underlying
principle of DXA is its ability to quantify the attenuated
radiation after its passage through bone and soft tissue
using either K-edge filters or pulsed power sources to the
x-ray tube. Subsequently, the differential attenuation of
the two energies is utilized to quantify bone, lean, and/or
fat tissue. The earlier DXA series are based on pencil-beam
absorptiometry, where a highly collimated x-ray beam
and a detector move along the rectilinear scan path. The
new series employ fan-beam absorptiometry in which
data are acquired either simultaneously along the entire
scan line, or as rectilinear scanning with a narrow fan-
beam, both resulting in a faster scanning time [1]. The fan
beam densitometers have the advantage of improved geo-
metrical resolution, but the disadvantage of errors
induced by magnification effects. Within the fan beam
instruments, the true fan beam densitometers have greater
accuracy and precision, shorter scan time, and wider scan
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field than limited-angle  fan beam densitometers which
have inherent overlap in acquisition, smaller number of
detectors, and poorer image quality [3].
The three major commercial manufacturers of bone den-
sitometers are GE Medical Systems Inc. (former Lunar),
Madison, WI; Hologic Inc., Waltham, MA; and Cooper-
Surgical (former Norland Medical Systems, Inc.), Trum-
bull, CT. Although each of these companies employs a
subtly different technology, our further discussion does
not address the particulars of each technology and/or
manufacturer. Our focus is the positioning of the over-
weight patients when obtaining densitometry scans and
subsequent analyses of these scans, overlooked in many
studies. However, for more information, the main physi-
cal characteristics of the most commonly used manufac-
turer/instruments are presented in Table 1.
DXA is considered one of the most precise technologies in
clinical medicine when the measurement of bone mineral
density (BMD) is considered, with the typical coefficients
of variation between 1–2% [4]. Nevertheless, there are
some limitations in BMD assessment as well. Results of in
vitro and in vivo studies indicate different manufacturers,
models, software versions and modes of analysis of densi-
tometers can lead to variations in the assessed BMD and
bone mineral content (BMC) in the same individuals
[5,6]. Laskey et al (2004) found that the GE Lunar Prodigy
gave significantly higher BMD, BMC and t-scores com-
pared to the GE Lunar MD in 10 volunteers [6]. They also
found that an increase in tissue depth (as in overweight
individuals) caused an increase in the measured BMC and
BMD for the MD model but not the Prodigy model, even
when using the appropriate and same scan modes [6]. The
prudent way to overcome these flaws would be to use the
same instrument and software version throughout a single
longitudinal study.
The accuracy of DXA instruments for measurement of soft
tissue is also questioned due to various methodological
limitations. Some of the limitations are addressed in a
recent review [7] and are generally attributed to the hard-
ware (fan- or pencil-beam) or software versions [8]. DXA
instruments from different manufactures are shown to
give considerably different soft tissue assessments of the
same individual [9]. Lunar and Hologic are shown to give
major differences in measurements of total body and
regional body fat in HIV patients (2.4–13.4% higher val-
ues for Hologic) and in body fat distribution [9]. Addi-
tionally, individuals' hydration levels may affect
calculations for soft tissue [7] whereas tissue thickness
may affect beam magnification, especially if the proper
scan mode is not chosen and in cases involving changes in
subject's weight [10]. Also, estimates for soft tissue in
regions directly adjacent to the large bony areas such as
the trunk, arms and head, may result in decreasing preci-
sion. During the total body scans (to obtain body compo-
sition analysis) a larger pixel size is utilized and pixels that
include smaller portions of bone may be counted as lean
tissue [10]. Despite the above flaws, DXA can still be used
for fairly accurate assessment of soft tissue composition or
its change [7], particularly for groups and large-scale epi-
demiological studies, provided that its limitations are
considered and adequately accounted for. However, it has
to be noted that DXA technology is not approved by Food
and Drug Administration for the individual assessment of
body composition.
Currently, the most accurate method for measuring body
composition is considered to be the four-compartment
(4C) model in which fat free body tissue is divided into its
constituent parts, namely water, protein and mineral. The
4C model then incorporates independent measurements
of mineral, total body water and body density to derive
body fat. The 4C model (though not a true gold standard)
is often used as a criterion method to compare the accu-
racy of other methods for assessing body fat. This method
however, is costly and time consuming and therefore not
generally used in clinical settings. DXA (a two-compart-
ment method) does not measure body water, which limits
its accuracy in body composition assessment. However,
since DXA offers quick and easy body fat assessment and
is considered superior to many other methods, it is often
used in clinical settings. Gately et al. [11] compared vari-
ous body composition methods for assessing body fat in
overweight and obese children. They found air-displace-
ment plethysmography and DXA to be the most promis-
ing methods for body fat assessment in a clinical setting
[11]. A study in non-obese women found DXA to be supe-
rior to waist circumference and waist-to-hip ratio in pre-
dicting intra abdominal fat [12].
The use of DXA for assessment of body composition in
overweight/obese individuals increased recently due to
numerous weight reduction studies. While all of the
above limitations of bone densitometers have been fre-
Table 1: Weight limits and table dimensions of full-size 
densitometers of various manufactures and models




GE Lunar Prodigy Advance 159 (350) 197.5 × 60
GE Lunar Prodigy 136 (300) 197.5 × 60
GE Lunar DPX-MD 136 (300) 196.8 × 57.6
Hologic QDR series 136 (300) 195.6 × 65- 67
Hologic Discovery Series 159 (350) 195.6 × 67
Norland XR-46 114 (250) 193 × 64
Norland XR-36 114 (250) 193 × 64BMC Medical Imaging 2005, 5:1 http://www.biomedcentral.com/1471-2342/5/1
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quently addressed, the limitations of assessing body com-
position in overweight individuals due to incorrect
positioning and subsequent failures to properly analyze
the obtained scans have not received any attention and are
the focus of this report. We discuss proper ways of meas-
uring overweight individuals and assessing their soft tis-
sue and point to some studies where that may not have
been the case.
Discussion
Use of bone densitometers in weight loss studies
In weight loss studies where DXA is used to evaluate lean
and fat tissue, overweight/obese individuals range widely
in body weight and size [8,13-20]. However, the maxi-
mum size of a DXA scanning table is limited to about
193–197 cm length and 58–65 cm width, with weight
limitations from 114–159 kg depending on the manufac-
turer and model, Table 1. In order to fit an overweight
individual within the scanning area, rice bags and straps
are used to press the limbs as close to the body as possible
[2]. Despite these measures, some large individuals can-
not fit within the global region of the scan area. Addition-
ally, in some cases, the space between the scanning table
and the detector is not large enough to accommodate
individuals with a larger chest girth, making their meas-
urements difficult or impossible.
While some authors do address these limitations when
reporting their data [14], some do not describe or vaguely
describe DXA assessment [13,15,17,19] or are unclear
regarding precision of their instruments in overweight
individuals [15-18,20]. In our own preliminary studies
with overweight women using a Lunar pencil-beam den-
sitometer, the coefficients of variation (CV) for different
skeletal sites ranged from 0.6–1.8% [21], but those for the
soft tissue were higher reaching 8.2% for fat tissue in the
arms (not published). The high %CVs (range 3.1–4.3%)
for fat tissue (even in normal-weight individuals) were
reported by others using pencil-beam instruments [22].
Figure 1 shows a total body scan of a 104 kg woman where
portions of the arms fell out of the scan area, and there-
fore, could not be included in the analysis of the total
body soft tissue. Furthermore, since her limbs were
pressed against the sides of her body, overlap of tissue
occurred in the chest, arm and hip regions, resulting in
inaccurate regional soft tissue analysis (namely, trunk,
legs and arms). Figure 2 presents the proper positioning
and analysis of total body composition in a 59 kg woman.
It is obvious that the inclusion of subjects who do not fit
in the global scan area might lead to questionable accu-
racy of both total and regional soft tissue estimates.
Total body and regional soft tissue assessment
When total body soft tissue assessment is the goal, it is
necessary to include all parts of the body in the scanning
area. In overweight subjects, overlapping of body parts
may affect the total results due to increased thickness in
overlapping regions. Another source of error is the head,
where tissue type cannot be distinguished. Specifically,
the brain tissue cannot be measured by DXA due to the
surrounding skull – it has to be assumed. Therefore, the
assessment of soft tissue in this region is subject to large
error and it is suggested the head be excluded from total
body soft tissue analysis [10]. In regional assessment,
DXA utilizes the placement of standard cut-lines to assess
the arms, legs and trunk (chest, abdomen, pelvis), Figure
1 and 2. Each regional estimate may be subject to error in
overweight individuals (in normal-weight ones too) if
overlapping of regions occurred. Wang et al. [13] meas-
ured total and regional body fat with DXA in women
(mean ± SD weight, 96 ± 11 kg) before and after weight
loss. Since the positioning of the subjects was not
described, it is not known whether all subjects fit within
the scan area and whether tissue overlap occurred. Similar
uncertainty exists in other studies [18,19].
In the newest study by Sun et al. [20] researchers com-
pared the assessment of total body fat by multi-frequency
bioelectrical impedance with DXA measurements as the
"gold standard". The subjects in the study ranged in
weight from 45 to 157 kg, with body mass index (BMI)
ranging from 17 to 55 kg/m2, indicating some were
severely obese. However, authors did not address the posi-
tioning or fitting of the obese subjects on the scanning
table, therefore it could only be speculated about the ade-
quacy of these measurements/analyses.
Researchers have found estimates of abdominal fat tissue
by DXA to be similar to computed tomography (CT) and
MRI-derived measurements in normal and overweight
individuals of wide age range, indicating DXA can accu-
rately estimate abdominal fat [24-26]. The abdominal
region is not a routinely defined region by DXA software
and therefore, must be manually determined (see Figure
1), which can differ among research sites. Park et al. [24]
compared abdominal adipose tissue measured by MRI
and DXA in non-obese men. They defined DXA regions of
interest in two different ways (between the second-lumbar
vertebra and the fourth-lumbar vertebra, or iliac crest) and
found both of these regions comparable with MRI total
abdominal adiposity and with MRI-derived narrow
abdominal slices. Bertin et al. [26] reported DXA yielded
accurate measurements of abdominal adipose tissue com-
pared with CT in overweight/obese individuals weighing
66–134 kg. They manually defined DXA abdominal
region to range from the acromion to the iliac crest, a
slightly different placement than the ones described
above, and compared it to a 10 mm region at the fourth-
lumbar vertebrae measured by CT. It is important to note
that the abdominal regions of interest could be subject toBMC Medical Imaging 2005, 5:1 http://www.biomedcentral.com/1471-2342/5/1
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Total body scan, with bones only (left) and with soft tissue (right), of a 104 kg woman (BMI = 34.1 kg/m2) Figure 1
Total body scan, with bones only (left) and with soft tissue (right), of a 104 kg woman (BMI = 34.1 kg/m2). Portions of the arms 
fell out of the scan area and there is overlapping tissue in the chest, arm, and hip regions. The abdominal and thigh regions of 
interest can be defined manually, while others are determined by computer software, although they can be manually changed as 
well.BMC Medical Imaging 2005, 5:1 http://www.biomedcentral.com/1471-2342/5/1
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potential error if the upper limbs are positioned in too
close contact with the trunk, causing the overlap of the
regions.
Researchers have also found estimates of different regions
of leg soft tissue extracted from the total DXA scans to be
reliable in elderly subjects of wide weight range [8,26,27].
Similarly, fat tissue of the thigh determined by DXA was
comparable to CT derived measurements in normal and
overweight individuals. Tylavsky et al. [8] compared CT
derived measurements of lean and fat tissue with DXA
measurements of a manually defined sub-region of the
mid-thigh (one-half the distance between the knee joint
and the top of the femur, see Figure 1). They indicated a
good assessment of soft tissue change by DXA in that
region. It therefore appears that with large individuals,
DXA should be used for assessing body composition of
defined regions such as the mid-thigh or abdominal
rather than the total body.
Half-body DXA scans for the assessment of soft tissue
Tataranni and Ravussin [28] suggest measuring soft tissue
of obese individuals by scanning only one side of the
body. They found total body composition results from
right and left sides only differed minimally in both over-
weight and normal-weight individuals. The half-body
scan can be performed by placing the central line of the
scanning area through the midpoint of the left or right
collar bone for each half-body scan. During analysis of the
half-body scans, the central line is then repositioned on
each half scan, and the side of the body that was not com-
pletely included in the scan area is deleted. The authors
found that small errors in estimates of soft tissue can
occur from imperfect positioning of the central line by the
operator or by true anatomical differences between the
left and right sides of the body. To minimize these errors,
they suggest fat tissue be determined by multiplying per-
cent body fat from the half-body scan by body weight, and
lean tissue be determined as the difference between body
weight and estimated fat tissue. Another possibility for
improving accuracy of soft tissue assessment would be
measuring both halves of the body, and then adding them
up. However, more research on the above methods is nec-
essary in order to make recommendations
Total body bone mineral assessment in overweight 
individuals
Similarly to problems with soft tissue assessment, there
are problems with bone mass assessment when DXA is
used in overweight individuals. When an individual does
not fit within the scan region, there is subsequent loss of
soft and bone tissue. Additionally, some anomalies in
bone mass measurement during weight loss studies using
different instruments were reported earlier [29]. Tothill et
al. [29], re-analyzed published results of changes in total
body bone mineral during weight change. The authors
found weight change leads to considerable anomalies in
measuring changes in bone mineral in all three brands of
DXA machines (Hologic, Lunar and Norland), with the
most serious ones occurring with Hologic [29]. These
inaccuracies were suspected to be due to the use of differ-
ent software modes (enhanced vs. standard) and the dif-
ferent assumptions manufactures make regarding fat
Total body scan of a 59 kg woman (BMI = 22.6 kg/m2) show- ing proper positioning on the scan table and no overlapping  regions Figure 2
Total body scan of a 59 kg woman (BMI = 22.6 kg/m2) show-
ing proper positioning on the scan table and no overlapping 
regions.BMC Medical Imaging 2005, 5:1 http://www.biomedcentral.com/1471-2342/5/1
Page 6 of 7
(page number not for citation purposes)
distribution [29]. Phantom studies using Lunar and
Hologic fan beam scanners showed bone mass measure-
ments were not compromised by magnification effects,
however, the height of bone and changes in body weight
simulated with lard did affect the accuracy of BMD and
BMC measurements [30]. Tothill and Hannan [30] com-
pared Lunar and Hologic DXA fan bean scanners for
measuring total body bone and soft tissue. Phantom
measurements revealed that both fan beam instruments
were subject to minor magnification effects, and measure-
ments of BMD and BMC were both dependent on the
height of a bone [30].
Summary
Current bone densitometers are limited to a scanning area
that cannot accommodate some overweight/obese indi-
viduals. Newer fan-beam densitometers have a wider scan
field [3] or can accommodate individuals up to 159 kg,
Table 1, making them a better option for body composi-
tion assessment. Unless researchers are using some of the
newer densitometers (with a scan table large enough to
accommodate larger body sizes) they may need to rely on
estimates of regional fat, namely the thigh or abdominal
region when assessing the body composition of many
overweight subjects. Using one or two half-body scans
may provide a relatively accurate measurement of total
body fat, however, more studies using this technique are
needed. The results of some published studies in over-
weight/obese individuals need to be interpreted with cau-
tion, since they may have included subjects who could not
properly fit within the scan area. Researchers using bone
densitometers for body composition measurements need
to have an understanding of its limitations in overweight
individuals and appropriately address the stated concerns
when interpreting their results. Authors also need to pro-
vide details of their DXA instrument including the manu-
facturer, the software version and the analysis mode used
for body composition assessment when reporting their
results. Studies on accuracy and precision in measure-
ments of both bone and soft tissue composition in over-
weight individuals, using available densitometers, are
warranted and needed.
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